ACRIVON THERAPEUTICS INC's ticker is and the CUSIP is 004890109. A total of 1 filers reported holding ACRIVON THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 1,652,605 | $15,798,904 | 4.67% |
| Perceptive Advisors | 3,007,858 | $28,755,122 | 0.96% |
| RA Capital Management | 4,810,508 | $45,988,456 | 0.90% |
| NEA Management Company, LLC | 430,252 | $4,113,209 | 0.32% |
| DAFNA Capital Management LLC | 76,852 | $734,705 | 0.23% |
| AAF Wealth Management, LLC | 10,678 | $102,082 | 0.07% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 105,000 | $1,003,800 | 0.02% |
| MARSHALL WACE, LLP | 597,469 | $5,711,804 | 0.01% |
| FEDERATED HERMES, INC. | 226,375 | $2,164,145 | 0.01% |
| EXCHANGE TRADED CONCEPTS, LLC | 9,919 | $94,826 | 0.00% |